One Gene Edit Could Control Cholesterol for Life

Imagine controlling your cholesterol with one treatment instead of daily pills for the rest of your life. That future just got closer.

Scientists at Verve Therapeutics published results in the New England Journal of Medicine showing their experimental gene therapy reduced bad cholesterol by up to 62% in 35 patients. The single infusion targets liver cells to permanently change how the body processes cholesterol.

The therapy works by editing a gene called PCSK9. About 20 years ago, researchers discovered that people born with mutations in this gene naturally have very low cholesterol and rarely develop heart disease, with no other health problems.

Four drugs already exist that block this gene, but they require regular injections that many patients eventually stop taking. Between 30% and 50% of people quit after just one year because of the inconvenience.

VERVE-102 solves this problem differently. The gene therapy edits liver cells once, and those cells keep multiplying with the same beneficial change. Patients in the study maintained lower cholesterol for 18 months so far, and animal studies show the effect lasting at least three years.

Dr. Sek Kathiresan, CEO of Verve Therapeutics, calls it giving protection to people who weren't born with it. His team plans to follow the 35 patients for 15 years to track long-term safety.

The treatment caused temporary increases in one liver enzyme, but no other serious side effects appeared. The next trial will include 200 patients to test effectiveness in people who've already had heart attacks or strokes.

Why This Inspires

Heart disease kills more people worldwide than any other condition. Millions struggle to take daily medications or can't afford regular treatments, watching their health decline despite knowing what needs to change.

This breakthrough offers something different: one treatment that could protect hearts for decades. It transforms prevention from a daily burden into a single decision, potentially saving countless lives lost to skipped pills and missed appointments.

The therapy still needs larger trials before reaching patients, but the science works. Real people already have measurably lower cholesterol from one infusion, proving we can rewrite genetic destiny.

For the first time, lifelong protection against heart disease might require just one day in a clinic.